BRIEF-GB Sciences Pursues FDA-Registered, First-In-Human Trial Of Cannabis Based Therapy For Parkinson's Disease

April 10 (Reuters) - GB Sciences Inc:

* BASED THERAPY FOR PARKINSON’S DISEASE

* EXPECTS TO COMMENCE ITS FIRST-IN-HUMAN TRIAL IN EARLY 2019

* COMPANY WILL BEGIN ITS TOXICOLOGY STUDIES IN SUMMER OF 2018 Source text for Eikon: Further company coverage: